← 홈

HER2+ 유방암

426개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 426개
AntibodystaleMerckPhase 2

pembrolizumab (Keytruda, Pembrolizumab - 4 cycle)

Breast Neoplasms; Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
효능 ORR 84%임상시험 31상태 RECRUITING
AntibodystaleMerckPhase 2

pembrolizumab (Keytruda, Pembrolizumab - 8 cycle)

Breast Neoplasms; Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
효능 ORR 25%임상시험 31상태 RECRUITING
AntibodystaleRochePhase 2

trastuzumab (Herceptin, Pertuzumab + trastuzumab)

Elderly Metastatic Breast Cancer Population · Elderly Metastatic Breast Cancer Populat

#ElderlyMetastaticBreastCancerPop#Antibody#Phase2#항체#면역항체+2
효능 ORR 69.3%임상시험 31상태 ACTIVE
AntibodystaleRochePhase 2

trastuzumab (Herceptin, Pertuzumab and Trastuzumab)

Breast Neoplasms; Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
효능 ORR 69.3%임상시험 31상태 RECRUITING
ADCBiologicstaleInstitut Claudius RegaudApproved

Pharmacokinetics blood samples (Pharmacokinetics blood samples)

Locally Advanced or Metastatic Breast Cancers · Locally Advanced or Metastatic Breast Ca

#LocallyAdvancedorMetastaticBreas#ADC#Approved#항체약물접합체#antibody-drug-conjugate+1
효능 ORR 91.2%임상시험 31상태 RECRUITING
ADCBiologicstaleBellicum PharmaceuticalsPhase 2

Rimiducid (Rimiducid)

Acute Lymphoblastic Leukemia; Leukemia, Acute Myeloid (AML), Child · Breast Cancer

#BreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+4
임상시험 31상태 RECRUITING
ADCBiologicstaleRemeGen Co., Ltd.Phase 2

Sequential CTX (Sequential CTX)

Breast Cancer · Breast Cancer

#BreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
효능 ORR 81.1%임상시험 31상태 RECRUITING
ADCBiologicstaleRemeGen Co., Ltd.Phase 2

Sequential Epirubicin (Sequential Epirubicin)

Breast Cancer · Breast Cancer

#BreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
효능 ORR 91.8%임상시험 31상태 RECRUITING
ADCBiologicstaleNuvalent Inc.Preclinical

TKIs (TKIs)

Breast Cancer · Breast Cancer

#BreastCancer#ADC#Preclinical#항체약물접합체#antibody-drug-conjugate+1
효능 ORR 18%임상시험 31상태 ACTIVE
ADCBiologicstaleBristol-Myers SquibbPhase 2

Taxane Chemotherapy (Taxane Chemotherapy)

HER2 + Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 81.1%임상시험 31상태 RECRUITING
ADCBiologicstaleSWOG Cancer Research NetworkPhase 3

Taxane Compound (Taxane Compound)

Anatomic Stage IV Breast Cancer AJCC v8; Metastatic HER2-Positive Breast Carcinoma · HER2

#HER2#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 69.3%임상시험 31상태 RECRUITING
AntibodystaleRochePhase 3

trastuzumab (Herceptin, Trastuzumab+ chemotherapy)

HER2-positive Advanced Breast Cancer · HER2

#HER2#Antibody#Phase3#항체#면역항체+3
효능 ORR 88.6%임상시험 31상태 RECRUITING
ADCBiologicstaleOHSU Knight Cancer InstitutePhase 1

Tretinoin (Tretinoin)

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Anatomic Stage IV Breast Cancer AJCC v8 · FRα

#FR#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+4
효능 ORR 100%임상시험 31상태 DISCONTINUED
AntibodystaleJazz PharmaceuticalsPhase 2

Zanidatamab (ZW25, ZW25 (Zanidatamab))

HER2+/HR+ Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
효능 ORR 34%임상시험 31상태 ACTIVE
ADCBiologicstaleChipscreen Biosciences, Ltd.Phase 3

taxane drug (taxane drug)

HER2-positive Metastatic Breast Cancer; First-line Treatment · HER2

#HER2#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 81.1%임상시험 31상태 RECRUITING
AntibodystaleQuantumLeap Healthcare Collabor…Phase 2

AMG 479 (AMG 479, Ganitumab, AMG 479 (Ganitumab) plus Metformin)

Breast Neoplasms; Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
효능 ORR 27%임상시험 30상태 RECRUITING
ADCBiologicAstraZenecaderuxtecan and rilvegostomi…Phase 2

Rilvegostomig (AZD8205 and AZD2936, AZD8205 and AZD2936 (Rilvegostomig))

Breast Cancer; Biliary Tract Carcinoma · Breast Cancer

#BreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+4
임상시험 30상태 RECRUITING
ADCBiologicstaleLaura Huppert, MD, BAPhase 2

Amiloride (Amiloride)

HER2 Low Breast Carcinoma; Triple Negative Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 30상태 RECRUITING
AntibodystaleRochePhase 3

trastuzumab (Herceptin, Docetaxel combined + Trastuzumab +Pertuzumab)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase3#항체#면역항체+2
효능 ORR 91.8%임상시험 30상태 RECRUITING
AntibodystaleRochePreclinical

trastuzumab (Herceptin, Docetaxel combined with Trastuzumab±Pertuzumab)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Preclinical#항체#면역항체+2
효능 ORR 91.8%임상시험 30상태 ACTIVE

5 / 22 페이지

← 이전다음 →